Case Report
 
Atypical BCR-ABL fusion transcript (e6a2) in pediatric acute lymphoblastic leukemia
Dushyant Kumar1, Manoj Kumar Panigrahi1, Deepti Dewangan2, Sarjana Dutt3, Khaliqur Rahman4, Anurag Mehta5
1M.Tech, Jr. Scientist, Molecular Biology Lab, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
2B. Tech, Jr. Scientist, Molecular Biology Lab, GenX Diagnostic, Delhi, India.
3Phd, Associate Director, Research and Development, Oncquest Laboratory Ltd., Delhi, India.
4MD, Hematopathologist, Hematology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
5MD, Director, Lab Services and Blood Bank, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.

doi:10.5348/ijcri-2014-01-437-CR-10

Address correspondence to:
Dushyant Kumar
Jr. Scientist (Molecular Biology Lab)
Rajiv Gandhi Cancer Institute and Research Centre Sector-7 Rohini
Delhi
India 110085
Phone: +91 9891099329
Fax: +91 1127051059
Email: dushyant.leo@gmail.com

Access full text article on other devices

  Access PDF of article on other devices

[HTML Full Text]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]


How to cite this article
Kumar D, Panigrahi MK, Dewangan D, Dutt S, Rahman K, Mehta A. Atypical BCR-ABL fusion transcript (e6a2) in pediatric acute lymphoblastic leukemia. International Journal of Case Reports and Images 2014;5(1):45–49.


Abstract
Introduction: Among precursor-B-acute lymphoblastic leukemia cases, BCR-ABL translocation occurs in around 20–30% of adults and in ≤5% of children. Minor breakpoint transcripts (e1a2) are found in about 70% of positive BCR-ABL cases and major breakpoint transcripts (e13a2, e14a2) in about 30% cases. However, other atypical transcripts are sometimes observed.
Case Report: A rare form of chimeric BCR-ABL fusion transcript (e6a2) was detected in a pediatric patient with precursor-B-acute lymphoblastic leukemia by reverse transcriptase polymerase chain reaction. Sequence analysis of the fusion region of the amplified cDNA fragment showed an in-frame joining of exon 6 of the BCR gene and exon 2 of the ABL gene, giving rise to an e6a2 BCR-ABL transcript. This finding was also confirmed by fluorescent in situ hybridization.
Conclusion: The findings in this case shows that atypical BCR-ABL transcripts are detectable in acute lymphoblastic leukemia patients without M-BCR-rearrangements. Reverse transcriptase polymerase chain reaction using primers that allow for amplification of all known BCR-ABL transcripts is an appropriate method to detect these rare variants.

Keywords: BCR-ABL, PCR, FISH, e6a2


[HTML Full Text]   [PDF Full Text]

Author Contributions
Dushyant Kumar – Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Critical revision of the article, Final approval of the version to be published
Manoj Kumar Panigrahi – Analysis and interpretation of data, Drafting the article, Final approval of the version to be published
Deepti Dewangan – Analysis and interpretation of data Drafting the article, Final approval of the version to be published
Khaliqur Rahman – Conception and design, Critical revision of the article, Final approval of the version to be published
Sarjana Dutt – Analysis and interpretation of data, Critical revision of the article, Final approval of the version to be published
Anurag Mehta – Conception and design, Critical revision of the article, Final approval of the version to be published
Guarantor of submission
The corresponding author is the guarantor of submission.
Source of support
None
Conflict of interest
Authors declare no conflict of interest.
Copyright
© Dushyant Kumar et al. 2014; This article is distributed the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any means provided the original authors and original publisher are properly credited. (Please see Copyright Policy for more information.)



About The Authors

Dushyant kumaris Scientist in Molecular Biology Department at (Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India). His research interests include Leukemia. He intends to pursue PhD in future.



Manoj kumar Panigrahiis Jr. Scientist in Molecular Biology Department at Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India. His research interests include Leukemia. He intends to pursue PhD in future.



Deepti Dewanganis currently Jr. Scientist in Molecular Biology Department at GenX Diagnostic, New Delhi, India. Her research interests include Flow Cytometry. She intends to pursue PhD in future.



Sarjana Duttis Associate Director in R&D Department at Oncquest Laboratory Ltd. Her research interests include (Molecular Biology of Cancer). She intends to pursue (more research work on cancer) in future. She has published 8 research papers in academic journals.



Khaliqur Rahmanis Hematopathologist in Hematopatholy Lab at Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India. His research interests include Flow Cytometry. He has published 8 research papers in academic journals.



Anurag Mehtais Director Lab Services at Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India. His research interests include Molecular Biology of Cancer. He has published 15 research papers in academic journals.